Adrenergic influence on the internal urinary sphincter.
D000328:Adult; D004542:Ejaculation / Q000187:drug effects; D004809:Ephedrine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011183:Postoperative Complications / Q000188:drug therapy; D011312:Pressure; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000502:physiology*; D014521:Urethra / Q000294:innervation* / Q000502:physiology / Q000503:physiopathology; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy; D014550:Urinary Incontinence, Stress / Q000188:drug therapy; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology
D010643:Phenoxybenzamine; D008750:Methyldopa; D004809:Ephedrine